156 related articles for article (PubMed ID: 24520076)
1. LRH-1 governs vital transcriptional programs in endocrine-sensitive and -resistant breast cancer cells.
Bianco S; Brunelle M; Jangal M; Magnani L; Gévry N
Cancer Res; 2014 Apr; 74(7):2015-25. PubMed ID: 24520076
[TBL] [Abstract][Full Text] [Related]
2. The orphan nuclear receptor LRH-1 and ERα activate GREB1 expression to induce breast cancer cell proliferation.
Chand AL; Wijayakumara DD; Knower KC; Herridge KA; Howard TL; Lazarus KA; Clyne CD
PLoS One; 2012; 7(2):e31593. PubMed ID: 22359603
[TBL] [Abstract][Full Text] [Related]
3. LRH-1 controls proliferation in breast tumor cells by regulating CDKN1A gene expression.
Bianco S; Jangal M; Garneau D; Gévry N
Oncogene; 2015 Aug; 34(34):4509-18. PubMed ID: 25435372
[TBL] [Abstract][Full Text] [Related]
4. Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.
Salvati A; Melone V; Sellitto A; Rizzo F; Tarallo R; Nyman TA; Giurato G; Nassa G; Weisz A
Breast Cancer Res; 2022 Jul; 24(1):52. PubMed ID: 35850772
[TBL] [Abstract][Full Text] [Related]
5. Co-regulated gene expression by oestrogen receptor α and liver receptor homolog-1 is a feature of the oestrogen response in breast cancer cells.
Lai CF; Flach KD; Alexi X; Fox SP; Ottaviani S; Thiruchelvam PT; Kyle FJ; Thomas RS; Launchbury R; Hua H; Callaghan HB; Carroll JS; Charles Coombes R; Zwart W; Buluwela L; Ali S
Nucleic Acids Res; 2013 Dec; 41(22):10228-40. PubMed ID: 24049078
[TBL] [Abstract][Full Text] [Related]
6. The liver receptor homolog-1 regulates estrogen receptor expression in breast cancer cells.
Thiruchelvam PT; Lai CF; Hua H; Thomas RS; Hurtado A; Hudson W; Bayly AR; Kyle FJ; Periyasamy M; Photiou A; Spivey AC; Ortlund EA; Whitby RJ; Carroll JS; Coombes RC; Buluwela L; Ali S
Breast Cancer Res Treat; 2011 Jun; 127(2):385-96. PubMed ID: 20607599
[TBL] [Abstract][Full Text] [Related]
7. BRCA1-mimetic compound NSC35446.HCl inhibits IKKB expression by reducing estrogen receptor-α occupancy in the IKKB promoter and inhibits NF-κB activity in antiestrogen-resistant human breast cancer cells.
Nathan S; Ma Y; Tomita YA; De Oliveira E; Brown ML; Rosen EM
Breast Cancer Res Treat; 2017 Dec; 166(3):681-693. PubMed ID: 28808806
[TBL] [Abstract][Full Text] [Related]
8. The nuclear receptor liver receptor homolog-1 is an estrogen receptor target gene.
Annicotte JS; Chavey C; Servant N; Teyssier J; Bardin A; Licznar A; Badia E; Pujol P; Vignon F; Maudelonde T; Lazennec G; Cavailles V; Fajas L
Oncogene; 2005 Dec; 24(55):8167-75. PubMed ID: 16091743
[TBL] [Abstract][Full Text] [Related]
9. A suppressive role of guanine nucleotide-binding protein subunit beta-4 inhibited by DNA methylation in the growth of anti-estrogen resistant breast cancer cells.
Wang B; Li D; Rodriguez-Juarez R; Farfus A; Storozynsky Q; Malach M; Carpenter E; Filkowski J; Lykkesfeldt AE; Kovalchuk O
BMC Cancer; 2018 Aug; 18(1):817. PubMed ID: 30103729
[TBL] [Abstract][Full Text] [Related]
10. Wilms' tumor 1 suppressor gene mediates antiestrogen resistance via down-regulation of estrogen receptor-alpha expression in breast cancer cells.
Han Y; Yang L; Suarez-Saiz F; San-Marina S; Cui J; Minden MD
Mol Cancer Res; 2008 Aug; 6(8):1347-55. PubMed ID: 18708366
[TBL] [Abstract][Full Text] [Related]
11. Nuclear FGFR1 Regulates Gene Transcription and Promotes Antiestrogen Resistance in ER
Servetto A; Kollipara R; Formisano L; Lin CC; Lee KM; Sudhan DR; Gonzalez-Ericsson PI; Chatterjee S; Guerrero-Zotano A; Mendiratta S; Akamatsu H; James N; Bianco R; Hanker AB; Kittler R; Arteaga CL
Clin Cancer Res; 2021 Aug; 27(15):4379-4396. PubMed ID: 34011560
[TBL] [Abstract][Full Text] [Related]
12. Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance.
Imachi H; Murao K; Dobashi H; Bhuyan MM; Cao X; Kontani K; Niki S; Murazawa C; Nakajima H; Kohno N; Yamashita H; Iwase H; Hayashi S; Ishida T; Yamauchi A
Breast Cancer Res Treat; 2010 Jul; 122(2):395-407. PubMed ID: 19847644
[TBL] [Abstract][Full Text] [Related]
13. KLF17 attenuates estrogen receptor α-mediated signaling by impeding ERα function on chromatin and determines response to endocrine therapy.
Ali A; Ielciu I; Alkreathy HM; Khan AA
Biochim Biophys Acta; 2016 Jul; 1859(7):883-95. PubMed ID: 27107895
[TBL] [Abstract][Full Text] [Related]
14. The branched-chain amino acid transaminase 1 sustains growth of antiestrogen-resistant and ERα-negative breast cancer.
Thewes V; Simon R; Hlevnjak M; Schlotter M; Schroeter P; Schmidt K; Wu Y; Anzeneder T; Wang W; Windisch P; Kirchgäßner M; Melling N; Kneisel N; Büttner R; Deuschle U; Sinn HP; Schneeweiss A; Heck S; Kaulfuss S; Hess-Stumpp H; Okun JG; Sauter G; Lykkesfeldt AE; Zapatka M; Radlwimmer B; Lichter P; Tönjes M
Oncogene; 2017 Jul; 36(29):4124-4134. PubMed ID: 28319069
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of the HDAC9 gene is associated with antiestrogen resistance of breast cancers.
Linares A; Assou S; Lapierre M; Thouennon E; Duraffourd C; Fromaget C; Boulahtouf A; Tian G; Ji J; Sahin O; Badia E; Boulle N; Cavaillès V
Mol Oncol; 2019 Jul; 13(7):1534-1547. PubMed ID: 31099456
[TBL] [Abstract][Full Text] [Related]
16. Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER
Formisano L; Stauffer KM; Young CD; Bhola NE; Guerrero-Zotano AL; Jansen VM; Estrada MM; Hutchinson KE; Giltnane JM; Schwarz LJ; Lu Y; Balko JM; Deas O; Cairo S; Judde JG; Mayer IA; Sanders M; Dugger TC; Bianco R; Stricker T; Arteaga CL
Clin Cancer Res; 2017 Oct; 23(20):6138-6150. PubMed ID: 28751448
[No Abstract] [Full Text] [Related]
17. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis.
Peng BL; Li WJ; Ding JC; He YH; Ran T; Xie BL; Wang ZR; Shen HF; Xiao RQ; Gao WW; Ye TY; Gao X; Liu W
Theranostics; 2020; 10(8):3451-3473. PubMed ID: 32206101
[TBL] [Abstract][Full Text] [Related]
18. AIB1 sequestration by androgen receptor inhibits estrogen-dependent cyclin D1 expression in breast cancer cells.
De Amicis F; Chiodo C; Morelli C; Casaburi I; Marsico S; Bruno R; Sisci D; Andò S; Lanzino M
BMC Cancer; 2019 Nov; 19(1):1038. PubMed ID: 31684907
[TBL] [Abstract][Full Text] [Related]
19. STAT1 facilitates oestrogen receptor α transcription and stimulates breast cancer cell proliferation.
Hou Y; Li X; Li Q; Xu J; Yang H; Xue M; Niu G; Zhuo S; Mu K; Wu G; Li X; Wang H; Zhu J; Zhuang T
J Cell Mol Med; 2018 Dec; 22(12):6077-6086. PubMed ID: 30334368
[TBL] [Abstract][Full Text] [Related]
20. Tamoxifen Resistance in Breast Cancer Is Regulated by the EZH2-ERα-GREB1 Transcriptional Axis.
Wu Y; Zhang Z; Cenciarini ME; Proietti CJ; Amasino M; Hong T; Yang M; Liao Y; Chiang HC; Kaklamani VG; Jeselsohn R; Vadlamudi RK; Huang TH; Li R; De Angelis C; Fu X; Elizalde PV; Schiff R; Brown M; Xu K
Cancer Res; 2018 Feb; 78(3):671-684. PubMed ID: 29212856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
